Cargando…
Samidorphan/olanzapine combination therapy for schizophrenia: Efficacy, tolerance and adverse outcomes of regimen, evidence-based review of clinical trials
INTRODUCTION: Schizophrenia is a complex medical illness characterized by hallucinations, delusions, and cognitive issues. Olanzapine, a second-generation antipsychotic widely prescribed for schizophrenia has proven to be efficacious, however, its use is associated with major adverse effects such as...
Autores principales: | Rehan, Syeda Tayyaba, Siddiqui, Abdul Hannan, Khan, Zayeema, Imran, Laiba, Syed, Abdul Ahad, Tahir, Muhammad Junaid, Jassani, Zahra, Singh, Manjeet, Asghar, Muhammad Sohaib, Ahmed, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289510/ https://www.ncbi.nlm.nih.gov/pubmed/35860157 http://dx.doi.org/10.1016/j.amsu.2022.104115 |
Ejemplares similares
-
The Facts and Fiction of Olanzapine-Samidorphan Fixed Dose Combination
por: Das, Nileswar, et al.
Publicado: (2022) -
Perioperative selenium administration in cardiac surgery patients, a way out to reduce post surgical adversities? A meta analysis
por: Rehan, Syeda Tayyaba, et al.
Publicado: (2023) -
Population Pharmacokinetics of Olanzapine and Samidorphan When Administered in Combination in Healthy Subjects and Patients With Schizophrenia
por: Sun, Lei, et al.
Publicado: (2021) -
Combining samidorphan with olanzapine to mitigate weight gain as a side effect in schizophrenia treatment
por: Grywińska, Weronika B., et al.
Publicado: (2023) -
Pegcetacoplan ‐ a novel C3 inhibitor for paroxysmal nocturnal hemoglobinuria
por: Rehan, Syeda Tayyaba, et al.
Publicado: (2022)